Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells

Oncology Reports

Volumn 27, Issue 4, 2012, Pages 917-922

  Huang, Liyong ^a,b   Xu, Ye ^a,b   Cai, Guoxiang ^a,b   Guan, Zuqing ^a,b   Cai, Sanjun ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Colorectal cancer; Invasion; RNAi; S100A4

Indexed keywords

CADHERIN; CADHERIN 11; CALVASCULIN; GELATINASE B; MESSENGER RNA; SMALL INTERFERING RNA; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL ACTIVITY; CELL GROWTH; CELL INVASION; CELL LEVEL; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; UPREGULATION;

CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 10; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA INTERFERENCE; RNA, MESSENGER; S100 PROTEINS; TIME FACTORS; TRANSFECTION;

EID: 84863038957     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1598     Document Type: Article

References (38)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
2. Huerta S: Recent advances in the molecular diagnosis and prognosis of colorectal cancer. Expert Rev Mol Diagn 8: 277-288, 2008.
3. Huang LY, Xu Y, Cai GX, Guan ZQ, Sheng WQ, Lu HF, Xie LQ, Lu HJ and Cai SJ: S100A4 overexpression underlies lymph node metastasis and poor prognosis in colorectal cancer. World J Gastroenterol 17: 69-78, 2011.
4. Marenholz I, Volz A, Ziegler A, Davies A, Ragoussis I, Korge BP and Mischke D: Genetic analysis of the epidermal differentiation complex (EDC) on human chromosome 1q21: chromosomal orientation, new markers, and a 6-Mb YAC contig. Genomics 37: 295-302, 1996. (Pubitemid 26386953)
5. Mazzucchelli L: Protein S100A4: too long overlooked by pathologists? Am J Pathol 160: 7-13, 2002.
6. Marenholz I, Heizmann CW and Fritz G: S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 322: 1111-1122, 2004. (Pubitemid 39164640)
7. Barraclough R: Calcium-binding protein S100A4 in health and disease. Biochim Biophys Acta 1448: 190-199, 1998.
8. Micklem DR and Lorens JB: RNAi screening for therapeutic targets in human malignancies. Curr Pharm Biotechnol 8: 337-343, 2007. (Pubitemid 350268192)
9. Tuschl T and Borkhardt A: Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy. Mol Interv 2: 158-167, 2002.
10. Gentile A, Lazzari L, Benvenuti S, Trusolino L and Comoglio PM: Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesis. Cancer Res 71: 3132-3141, 2011.
11. Huang Z, Huang S, Wang Q, Liang L, Ni S, Wang L, Sheng W, He X and Du X: MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma. Cancer Res 71: 2582-2589, 2011.
12. Mortazavi F, Dubinett S and Rettig M: c-Crk proto-oncogene contributes to transcriptional repression of p120-catenin in non-small cell lung cancer cells. Clin Exp Metastasis 28: 391-404, 2011.
13. Mischke D, Korge BP, Marenholz I, Volz A and Ziegler A: Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ('epidermal differentiation complex') on human chromosome 1q21. J Invest Dermatol 106: 989-992, 1996.
14. Vallely KM, Rustandi RR, Ellis KC, Varlamova O, Bresnick AR and Weber DJ: Solution structure of human Mts1 (S100A4) as determined by NMR spectroscopy. Biochemistry 41: 12670-12680, 2002. (Pubitemid 35192496)
15. Zou M, Al-Baradie RS, Al-Hindi H, Farid NR and Shi Y: S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma. Br J Cancer 93: 1277-1284, 2005. (Pubitemid 41679414)
16. Rudland PS, Platt-Higgins A, Renshaw C, West CR, Winstanley JH, Robertson L and Barraclough R: Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 60: 1595-1603, 2000. (Pubitemid 30183430)
17. Ai KX, Lu LY, Huang XY, Chen W and Zhang HZ: Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer. World J Gastroenterol 14: 1931-1935, 2008. (Pubitemid 351523827)
18. Ikenaga N, Ohuchida K, Mizumoto K, Yu J, Fujita H, Nakata K, Ueda J, Sato N, Nagai E and Tanaka M: S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma. J Gastrointest Surg 13: 1852-1858, 2009.
19. Tsuna M, Kageyama S, Fukuoka J, Kitano H, Doki Y, Tezuka H and Yasuda H: Significance of S100A4 as a prognostic marker of lung squamous cell carcinoma. Anticancer Res 29: 2547-1554, 2009.
20. Wang YY, Ye ZY, Zhao ZS, Tao HQ and Chu YQ: High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Ann Surg Oncol 17: 89-97, 2010.
21. Gongoll S, Peters G, Mengel M, Piso P, Klempnauer J, Kreipe H and von Wasielewski R: Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology 123: 1478-1484, 2002. (Pubitemid 35231647)
22. Boye K, Nesland JM, Sandstad B, Maelandsmo GM and Flatmark K: Nuclear S100A4 is a novel prognostic marker in colorectal cancer. Eur J Cancer 46: 2919-2925, 2010.
23. Kwak JM, Lee HJ, Kim SH, Kim HK, Mok YJ, Park YT, Choi JS and Moon HY: Expression of protein S100A4 is a predictor of recurrence in colorectal cancer. World J Gastroenterol 16: 3897-3904, 2010.
24. Wang HY, Zhang JY, Cui JT, Tan XH, Li WM, Gu J and Lu YY: Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery. Oncol Rep 23: 45-52, 2010.
25. Royston D and Jackson DG: Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J Pathol 217: 608-619, 2009.
26. Sundar SS and Ganesan TS: Role of lymphangiogenesis in cancer. J Clin Oncol 25: 4298-4307, 2007. (Pubitemid 47548571)
27. Brinckerhoff CE and Matrisian LM: Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3: 207-214, 2002.
28. Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67, 2010.
29. Saleem M, Kweon MH, Johnson JJ, Adhami VM, Elcheva I, Khan N, Bin HB, Bhat KM, Sarfaraz S, Reagan-Shaw S, Spiegelman VS, Setaluri V and Mukhtar H: S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci USA 103: 14825-14830, 2006. (Pubitemid 44527813)
30. Aung PP, Oue N, Mitani Y, Nakayama H, Yoshida K, Noguchi T, Bosserhoff AK and Yasui W: Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 25: 2546-2547, 2006.
31. Yen CY, Chen CH, Chang CH, Tseng HF, Liu SY, Chuang LY, Wen CH and Chang HW: Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers. Biomarkers 14: 244-249, 2009.
32. Brew K and Nagase H: The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 1803: 55-71, 2010.
33. Riddick AC, Shukla CJ, Pennington CJ, Bass R, Nuttall RK, Hogan A, Sethia KK, Ellis V, Collins AT, Maitland NJ, Ball RY and Edwards DR: Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues. Br J Cancer 92: 2171-2180, 2005. (Pubitemid 40966253)
34. Okazaki M, Takeshita S, Kawai S, Kikuno R, Tsujimura A, Kudo A and Amann E: Molecular cloning and characterization of OB-cadherin, a new member of cadherin family expressed in osteoblasts. J Biol Chem 269: 12092-12098, 1994. (Pubitemid 24196706)
35. Brieger J, Duesterhoeft A, Brochhausen C, Gosepath J, Kirkpatrick CJ and Mann WJ: Recurrence of pleomorphic adenoma of the parotid gland - predictive value of cadherin-11 and fascin. APMIS 116: 1050-1057, 2008.
36. Li Z, Zhou Z and Donahue HJ: Alterations in Cx43 and OB-cadherin affect breast cancer cell metastatic potential. Clin Exp Metastasis 25: 265-272, 2008.
37. Tamura D, Hiraga T, Myoui A, Yoshikawa H and Yoneda T: Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone. Int J Oncol 33: 17-24, 2008.
38. Chu K, Cheng CJ, Ye X, Lee YC, Zurita AJ, Chen DT, Yu-Lee LY, Zhang S, Yeh ET, Hu MC, Logothetis CJ and Lin SH: Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Mol Cancer Res 6: 1259-1267, 2008.